Home Forums Other Specialities Therapeutics UPDATE -JUNE 2015.

This topic contains 1 voice and has 0 replies.
1 voice
0 replies
  • Author
  • #2762

    Sirdupla: new LABA/corticosteroid inhaler

    Sirdupla (salmeterol/fluticasone) has been launched for use in adults with asthma where a long-acting ß2-agonist and inhaled corticosteroid is appropriate.

    Zevtera: a new cephalosporin antibiotic

    Basilea has launched Zevtera (ceftobiprole), a new intravenous antibiotic for the treatment of pneumonia.

    Imnovid: new safety warnings
    Healthcare professionals should be vigilant for signs or symptoms of cardiac failure, interstitial lung disease (ILD) and hepatotoxicity in patients taking the myeloma treatment pomalidomide (Imnovid), the MHRA has advised.

    Hepatitis C antivirals: risk of severe bradycardia
    Clinically significant arrhythmias have been reported when Harvoni (sofosbuvir + ledipasvir) or Daklinza (daclatasvir) in combination with Sovaldi (sofosbuvir) are given concomitantly with amiodarone.

    New treatment option for adolescents with schizophrenia
    The licensing of Invega (paliperidone) has been extended to include children from 15 years old with schizophrenia.

    G Mohan.

You must be logged in to reply to this topic.